Genomics in Oncology lecture series invites Fabrice André, Medical Oncologist and Director, Institut Gustave Roussy, Unité INSERM U981 in Paris. Professor André presents advances in breast cancer research, enabled by genomics, and shares his perspective on the important role of next generation sequencing for clinical trials.
Learn more about Genomics in Oncology, visit our website here.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel